< Back to previous page

Publication

NEO1 AND NEO-EXT STUDIES: PHARMACODYNAMIC/EXPLORATORY BIOMARKER AND SAFETY ASSESSMENTS FOLLOWING REPEAT AVALGLUCOSIDASE ALFA DOSING FOR UP TO 4.5 YEARS IN PATIENTS WITH LATE-ONSET POMPE DISEASE

Journal Contribution - Journal Article Conference Contribution

Journal: MUSCLE & NERVE

ISSN: 0148-639X

Volume: 60

Pages: S48 - S49

Publication year:2019

WoS Id: 000480524300096
Institutional Repository URL: https://lirias.kuleuven.be/2839575